Skip to main content
. 2022 Feb 25;17(2):e0264637. doi: 10.1371/journal.pone.0264637

Fig 2. Breast cancer-specific survival estimates1 for patients with early breast cancer, by HR, HER2 subtype.

Fig 2

1Survival estimates were derived using Kaplan-Meier methods with 95% Hall-Wellner confidence bands. SEER does not provide cancer-specific survival status for patients with a previous tumor, so those patients were excluded. ⸗ Indicates y-axis was truncated to 0.75–1.00. Abbreviations: HER, human epidermal growth factor receptor; HR, hormone receptor; SEER, Surveillance, Epidemiology, and End Results; TNBC, triple negative breast cancer.